227 related articles for article (PubMed ID: 11555723)
1. New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy.
Braun J; de Keyser F; Brandt J; Mielants H; Sieper J; Veys E
Curr Opin Rheumatol; 2001 Jul; 13(4):245-9. PubMed ID: 11555723
[TBL] [Abstract][Full Text] [Related]
2. Biologic therapies in the spondyloarthritis: new opportunities, new challenges.
Braun J; Brandt J; Listing J; Rudwaleit M; Sieper J
Curr Opin Rheumatol; 2003 Jul; 15(4):394-407. PubMed ID: 12819466
[TBL] [Abstract][Full Text] [Related]
3. Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.
Braun J; Sieper J
Arthritis Res; 2002; 4(5):307-21. PubMed ID: 12223105
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides.
Braun J; van der Heijde D
Expert Opin Investig Drugs; 2003 Jul; 12(7):1097-109. PubMed ID: 12831346
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic use of anti-TNF-alpha agents in spondyloarthropathies].
Wendling D; Claudepierre P; Lohse A; Toussirot E; Breban M
Presse Med; 2003 Oct; 32(32):1517-24. PubMed ID: 14534471
[TBL] [Abstract][Full Text] [Related]
6. Anti-TNFalpha: a new dimension in the pharmacotherapy of the spondyloarthropathies !?
Braun J; Sieper J
Ann Rheum Dis; 2000 Jun; 59(6):404-7. PubMed ID: 10834852
[No Abstract] [Full Text] [Related]
7. [Autoimmune aspects of treatment with TNF-alpha inhibitors].
Kolarz B; Targońska-Stepniak B; Darmochwał-Kolarz D; Majdan M
Postepy Hig Med Dosw (Online); 2007 Aug; 61():478-84. PubMed ID: 17786135
[TBL] [Abstract][Full Text] [Related]
8. New indications for treatment of chronic inflammation by TNF-alpha blockade.
Reimold AM
Am J Med Sci; 2003 Feb; 325(2):75-92. PubMed ID: 12589232
[TBL] [Abstract][Full Text] [Related]
9. Infliximab: 12 years of experience.
Smolen JS; Emery P
Arthritis Res Ther; 2011 May; 13 Suppl 1(Suppl 1):S2. PubMed ID: 21624181
[TBL] [Abstract][Full Text] [Related]
10. [Anti-TNF-alpha treatment and spondyloarthropathies].
Braun Y; Balbir-Gurman A
Harefuah; 2002 Nov; 141(11):965-8, 1010. PubMed ID: 12476631
[TBL] [Abstract][Full Text] [Related]
11. Anti-TNF-alpha therapy in ankylosing spondylitis.
De Keyser F; Van den Bosch F; Mielants H
Cytokine; 2006 Mar; 33(5):294-8. PubMed ID: 16516484
[TBL] [Abstract][Full Text] [Related]
12. [Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis].
Lanfant-Weybel K; Lequerré T; Vittecoq O
Presse Med; 2009 May; 38(5):774-87. PubMed ID: 19327945
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience.
Braun J; Sieper J; Breban M; Collantes-Estevez E; Davis J; Inman R; Marzo-Ortega H; Mielants H
Ann Rheum Dis; 2002 Dec; 61 Suppl 3(Suppl 3):iii51-60. PubMed ID: 12381511
[TBL] [Abstract][Full Text] [Related]
14. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
15. Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides.
Braun J; Baraliakos X; Brandt J; Sieper J
Scand J Rheumatol; 2005; 34(3):178-90. PubMed ID: 16134723
[TBL] [Abstract][Full Text] [Related]
16. Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis.
Kavanaugh A; Tutuncu Z; Catalan-Sanchez T
Curr Opin Rheumatol; 2006 Jul; 18(4):347-53. PubMed ID: 16763453
[TBL] [Abstract][Full Text] [Related]
17. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
[TBL] [Abstract][Full Text] [Related]
18. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
Sfikakis PP
Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of ankylosing spondylitis (Bechterew disease)].
Rudwaleit M; Sieper J
Dtsch Med Wochenschr; 2005 Aug; 130(33):1882-6. PubMed ID: 16118732
[No Abstract] [Full Text] [Related]
20. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
Tobin AM; Kirby B
BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
